News Release VacciXcell

Press Release

The global impact of rotavirus infection in infants and young children affects child morbidity and mortality worldwide at a high rate. Although first identified in animals in the 1960s, rotavirus (RV) was later discovered through the examination of a part of the small intestine (duodenum) of children who have severe diarrhea.

A Tide to Remember

Dec 07, 2018

Throughout 2018, Esco Aster and Esco VacciXcell have been very determined in providing solutions through the use of proprietary technologies, to make human lives healthier and safer.

Read More

The Ottawa Phenomena

Nov 09, 2018

PENNSYLVANIA — Canada's Till and McCulloch Stem Cell Meetings at Westin Ottawa Hotel is the only conference of its kind to provide unparalleled opportunities this Nov. 12-14.

Read More

Acute Flaccid Myelitis: A Rare Disease for Children

Nov 08, 2018

Acute Flaccid Myelitis (AFM), is a rare disease affecting the nervous system and is caused by the Enterovirus 68. Since AFM affects the nerves, it can weaken not only the arms and the legs, but also respiratory muscles, which can lead to respiratory failure. Many symptoms of AFM develop after a viral infection such as poliovirus, West Nile virus, and adenovirus. Hence, some cases have a clear correlation why some infected people develop AFM.

Read More

JEV WAVE
The Disease Beyond Borders

Sep 28, 2018

Japanese encephalitis virus or JEV is a debilitating mosquito-borne Flavivirus disease that belongs to the same genus as dengue, yellow fever, and West Nile viruses. The rise of global transportation, trade, and climate change allow insects to easily carry disease thus, infecting animals as well as humans. Most JEV infections are endemic in tropical and subtropical regions. It later causes death when left untreated.

Read More

The Tide is Rolling to Europe!

Sep 27, 2018

Ola! Esco VacciXcell and Esco Aster will be exhibiting again for the upcoming World Vaccine Congress (WVC) at EPIC SANA Lisboa Hotel Lisbon, Portugal from Oct. 29 – 31.

Read More

Caring for Livestock

Aug 28, 2018

Agricultural animals play an important role in economic and socio-cultural aspects in terms of food supply, source of income, transport and so much more. These animals are taken care of to reproduce and to provide good quality products.

Read More

INNOVATIVE TECHNOLOGIES ARE HEADING EAST

Aug 24, 2018

PENNSYLVANIA – Bioprocess International (BPI) conference at Hynes Convention Center Boston got innovative technologies covered with more science, more new data, and more case studies this Sep. 4-7.

Read More

The Tide Motion Platform for Exosome Production
(Part 3 of 3)

Jul 27, 2018

Exosomes provide promise in its potential for therapeutic application. The role of these extracellular vesicles (EVs) as a nano-vehicle for transporting molecular payloads, is designed to treat diseases. For example, catalase incorporated in exosomes, targets and delivers this cargo to the brain tissue, leading to a promising option for Parkinson's Disease (PD) therapy.

Read More

Bangkok: A Rabies Red Zone

Jul 27, 2018

Since March 2018, Thailand has been trying to contain rabies outbreak by conducting vaccinations for 10 million cats and dogs around the country. According to the Department if Livestock Development (DLD) there have been 400 confirmed rabies cases with a total of 37 Thailand provinces that were declared temporary rabies epidemic zones. Due to this, people brought in pets to be vaccinated; as such, vaccines are now running low.

Read More

The-Unstoppable-CAR-T-Therapy

Jul 01, 2018

Chimeric antigen receptor (CAR) – T cell therapy is the first FDA approved immunotherapy to cure cancer. T cells are the backbone of this therapy because they are the killer cells of our immune system that fight foreign substances such as bacteria, viruses, or tumor cells.

Read More

EXOSOMES AT WORK
Part 2 of 3

Jun 29, 2018

The emerging role of exosomes as a natural nano-vehicle offers important advantages for drug delivery compared to other nanoparticulate delivery systems. Looking at a bigger picture, exosomes are a part of the family of “bioactive vesicles” that are involved in several biological and pathological processes.

Read More

Exosomes: The Bigger Picture
(Part 1 of 3)

May 31, 2018

The immune system has evolved its response to threats, protecting the host from pathogens. The ability of the immune system to differentiate itself from pathogens is through intercellular communication which is a key in this process. Cell to cell communication or signaling involves the transfer of chemokines, cytokines, and direct cell contact.

Read More

Fixing A Broken Heart

May 30, 2018

Stem cells are the most promising and most exciting area in medicine. Stem cells are unspecialized cells capable of renewing themselves through cell division. It can be induced to embody cells with special functions. Due to their potential in regenerating and repairing damaged tissues, scientists are exploring and optimizing stem cells abilities to treat different types of diseases.

Read More

Esco VacciXcell Attends the 26th Analytica!

May 29, 2018

Esco VacciXcell had the opportunity to showcase its Patented Tide Motion technology at Analytica, the international trade fair for analytics, biotechnology and modern laboratory processes. The 26th Analytica was held in Munich, Germany from April 10 – 13, 2018.

Read More

A Look Back: ISCT 2018

May 23, 2018

Esco VacciXcell looks back for the successful ISCT event held in Montreal, Canada last May 2-5, 2018. The response to this years event offered exciting possibilities for the evolution of cell therapy and how it seems to be pervasively expanding. From the promise of CAR-T therapies to Stem Cell Regenerative Medicine, there is a huge presence of how bioprocessing technologies become more accessible.

Read More

EVERY BREATH COUNTS!

May 03, 2018

Esophageal cancer is one of most frequently diagnosed cancer in Asia specifically in China and Japan. According to International Association of Cancer Registries (IACR), an estimated 17,497 new cases and 11,746 deaths in China; and 17,497 new cases and 11,746 deaths caused by esophageal cancer in Japan last year.

Read More

There's More to Canada!

Apr 26, 2018

Esco Aster, alongside with Esco VacciXcell will be back for the upcoming International Society for Cell Therapy (ISCT) 2018 at Palais Des Congres de Montreal, Canada from May 2 – 5, 2018.

Read More

Esco Aster and Esco VacciXcell Made It West!

Apr 24, 2018

Esco Aster, a leading CDMO company in ASEAN that utilizes Esco VacciXcell’s Tide Motion technology, jump started the year right. The recently held World Vaccine Congress at Renaissance Hotel, Washington D.C. last April 2-5, 2018 was a huge success, with lots of delegates worldwide brought together for a specific reason.

Read More

Producing Beauty in a Bottle

Apr 02, 2018

The word “beauty” comes in many definitions that change over time. Although beauty and preference are based on the individual’s taste and personality, beauty products help in a great way to enhance one’s external appearance.

Read More

Spread the Word and Get Vaccinated

Mar 30, 2018

Cervical cancer is the second most common causes of cancer death in the world especially in Southeast Asia. It is frequently diagnosed in women between the ages of 35 and 44. According to International Association of Cancer Registries, about 13, 240 new cases of invasive cervical cancer will be diagnosed and about 2, 170 women will die from cervical cancer this year.

Read More

HEAD EAST, GO DOWNTOWN!

Mar 01, 2018

Start off the year right! The 18th Annual World Vaccine Congress, which leads the largest event in gathering thousands of attendees, key speakers, and networking opportunities, will continue to progress this coming March 2 – 5, 2018 at Renaissance Washington DC Downtown Hotel.

Read More

We Are Stronger than Breast Cancer

Mar 01, 2018

According to American Society of Clinical Oncology (ASCO), more women are diagnosed with breast cancer than any other cancer. Breast cancer is a form of cancer that starts with an abnormal growth of cells in the breast tissue. These cells usually form a tumor, that can be malignant, growing into surrounding tissues invading other distant areas of the body.

Read More

Adeno-associated Virus in Gene Therapy

Feb 06, 2018

Adeno-associated virus (AAV) belongs to the family Parvoviridae and genus Dependovirus. Because of its non-pathogenicity, the medical field gave little to no interest at all. However, as gene therapy gains more attention, scientists are scrambling to find the best possible viral vectors for human gene therapy applications. AAV can target specific cells to correct disease-causing protein malfunction. Currently it is one of the commonly used viruses in gene

Read More

One Way to Make a Better and Effective Vaccine

Feb 05, 2018

Based on National Center for Health Statistics, 8.2% of death in the United States of America was caused by flu last December 30, 2017. The World Health Organization (WHO) is closely monitoring the evolution of influenza virus to produce the specific vaccine.

Read More

Esco Healthcare Welcomes 2018!

Jan 05, 2018

Esco Healthcare, a member of the Esco Group of companies, is comprised of 3 divisions namely, Esco Pharma, TaPestle Rx, and Esco VacciXcell. Altogether, these 3 divisions aim to make your 2018 a year of continuous learning for unsurmountable growth and development.

Read More

Beauty in a Bottle

Jan 05, 2018

Stem cell therapies have been widely known to treat numerous diseases such as cancer. However, stem cells have also been a huge head turner in the skin care world. Cosmeceutical science is advancing to discover and deliver skin treatments that can aid in skin regeneration, rejuvenation, and aging.

Read More

Keep Moving Forward!
TideCell® Closed System for Aseptic Bioprocessing

Jan 04, 2018

Aseptic bioprocessing is a major challenge in vaccine manufacturing, whether for microbial, viral, recombinant protein, and polysaccharide vaccines. The operation, from cell culture to cell harvesting should be in a pristine environment.

Read More

ESCO ASTER AND INSTITUTE OF MOLECULAR CELL BIOLOGY ANNOUNCE A COLLABORATION TO ACCELERATE PRECLINICAL DEVELOPMENT OF A HAND FOOT AND MOUTH VACCINE

Dec 08, 2017

Singapore, December 07, 2018 - Esco Aster, a leading independent contract development and manufacturing organization dedicated to the Singapore's R&D ecosystem, has signed a research collaboration agreement with A*STAR's Institute of Molecular Cell Biology (IMCB). The collaboration will facilitate the quick development and commercialisation of a multivalent vaccine targeting Hand Foot and Mouth Disease (HFMD).

Read More

Dimension Attention

Dec 04, 2017

Therapeutic application of cells or cell-based therapy is a flourishing research field that offers a transformative approach to the healthcare industry. This type of research provides hope not only for treating incurable or rare diseases, but also the possibility to cure them. For the manufacture of cell-based therapies, cells are optimized to produce therapeutic agents. Generating an adequate number of cells with retained cell function and quality represents an essential factor for product effi

Read More

World Vaccine and Immunotherapy Congress | Coronado Bay Resort San Diego, CA

Nov 30, 2017

VacciXcell will unveil the new and improved TideCell®, a revolutionary bioprocessing adherent bioreactor, which utilizes the tide motion principle for the upcoming World Vaccine and Immunotherapy Congress. This event will give an in-depth look at the advancements in the integration of innovative technologies and its impact on immunotherapy and vaccine development.

Read More

Imagine the Possibilities: From Science to Society

Nov 08, 2017

VacciXcell is strengthening its core in bioprocessing for being one of the exhibitors of the upcoming Research Support Center Scientific Roadshow on November 14, 2017, starting from 9:30 am to 3:30 pm at Epicenter Matrix Biopolis, Singapore.

Read More

Continuous Bioprocessing

Oct 23, 2017

Biomanufacturing companies have long sought better approaches with regards to bioprocessing. Due to rapidly fluctuating market demands for biologics, there is a growing interest in the benefits of continuous bioprocessing, mainly for cell culture. This process had increasingly driven biomanufacturing companies to develop innovative solutions for highly flexible and cost-effective production.

Read More

Esco VacciXcell at World Vaccine Congress in Barcelona, Spain

Oct 20, 2017

Esco VacciXcell recently participated in the World Vaccine Congress Exhibition held in Crown Plaza Hotel Barcelona, Spain from October 10-12, 2017. The congress brought together scientific scope, breadth, and partners from around the globe.

Read More

Esco Life Sciences and Healthcare is Strengthening its Core in Biocontainment

Oct 12, 2017

From the world’s most certified Biological Safety Cabinet manufacturer, Esco is now the only manufacturer of biocontainment solutions with vertically integrated and regional factories to provide customized Class III Biological Safety Cabinets which exceed international standards from NSF 49 to EN 12469.

Read More

Esco VacciXcell Heads to the East!

Oct 05, 2017

Esco VacciXcell have recently participated in BioProcess International Conference and Exhibition 2017 last September 26-28 in Hynes Convention Center Boston, Massachusetts. The event brought science, technology, and partners to accelerate promising biologics towards commercial success.

Read More

Esco VacciXcell is Launching the New and Improved TideCell in the US

Sep 26, 2017

Esco VacciXcell is proud to launch the new TideCell® with enhanced features and now controlled by Siemens HMI/PLC in USA soil.

Read More

Stop POLIOMYELITIS Get Vaccinated

Sep 14, 2017

Poliomyelitis also known as Polio or infantile paralysis, is a highly contagious viral infection caused by poliovirus. It invades the nervous system and can cause irreversible paralysis, breathing problems and even death. It is caused by one of the three polioviruses from genus Enterovirus: Human poliovirus 1 (HPV1), Human poliovirus 2 (HPV2) and Human poliovirus 3 (HPV 3). Polio can strike at any age, but mainly affects children under 5 years old.

Read More

Esco Vaccixcell at International Society for Pharmaceutical Engineering (ISPE) 2017

Aug 29, 2017

The International Society for Pharmaceutical Engineering or ISPE was successfully concluded last August 23-26, 2017 at Suntec & Exhibition Centre in Singapore. This year’s theme “Innovating for Next Generation Pharma Manufacturing” involved a lot of bioprocessing companies and delegates from different companies around the Globe.

Read More

GlucCell: Your Glucose Meter Partner

Aug 10, 2017

Glucose is the main source of energy for cells specially in in-vitro cultures. Glucose gives cells the required energy in order to grow and proliferate. Sadly reserchers and scientists around the globe do not know the proper levels of glucose required by their culture. Learn why measuring glucose is important and what is the best way to do it.

Read More

CPhI China 2017

Jul 14, 2017

CPhI China brings together domestic and international pharmaceutical  companies every year to share ideas and innovations in China. LABWorld China 2017, in partnership with CPhI, is a grand exhibition held at the New International Expo Center, N1, Shanghai, China.

Read More

Man's Best Friend and Rabies

Jul 01, 2017

Rabies is a disease caused by a rabies virus of the genus Lyssavirus. It is most often transmitted from a bite of a rabid animal. The virus replicates in the animal carrying it and is retained in their salivary glands. Although dogs are commonly known to transmit rabies; skunks, bats, racoons, and foxes are among the animals that are reported to transmit vast majority of rabies cases. It is endemic on all continents except Antartica.

Read More

Introducing Aster BioPharma Contract Development and Manufacturing Organization (CDMO)

Jun 15, 2017

A CDMO or Contract Development and Manufacturing Organization is a contractual company that provides services like drug development and drug manufacturing in the healthcare industry. CDMO services running on Esco's VacciXcell are now provided by a new independent company called Esco Aster Biopharma.

Read More

9th HUMAN VACCINE AND 5th VETERINARY INDUSTRY SUMMIT, CHINA

Jun 14, 2017

Esco VacciXcell attended the recently concluded human vaccine and veterinary industry summit held in Four Points Hotel, Qing Dao, West Coast China. The event lasted 2 days, starting from June 13 and ending on June 14, 2017. The event commemorated two both the 9th Human Vaccine Industry Summit and the 5th Veterinary Industry Summit.

Read More

Do not let Yellow Fever ruin Summer

May 11, 2017

Planning for a vacation to that tropical paradise? Aside from having your plane ticket, hotel and itinerary ready maybe you should also consider getting vaccinated for yellow fever. Do not let yellow ruin your summer!

Read More

ISCT 2017

May 08, 2017

VacciXcell participated in the recently concluded ISCT 2017 held at ExCel London, United Kingdom last May 3-6, 2017. ISCT 2017 marks the 25th Anniversary of the International Society for Cellular Therapy. VacciXcell displayed their tide motion bioreactor systems which are perfect for cell proliferation such as those utilized in cellular therapy.

Read More

Korea Lab 2017

Apr 24, 2017

Esco VacciXcell participated in the recently concluded Korea Lab 2017 held last April 18-21, 2017 at Korea International Convention Center, Gyeonggi, South Korea. The event was attended mostly by professionals from the pharmaceutical, cell therapy and cosmetics industry.

Read More

Why Wave When You Can Tide

Apr 21, 2017

Tide motion is a novel and innovative system for high density culture of adherent cells. Learn why tide motion can solve all your adherent culture problems!

Read More

VacciXcell at World Vaccine Congress 2017

Apr 13, 2017

World Vaccine Congress USA successfully concluded another series last April 10-12, 2017 held at Grand Hyatt Washington DC. This year, the Congress brought together over 700 senior vaccine executives for debates and discussions exploring new vaccine technologies.

Read More

Understanding Vaccines: Attenuated vs Inactivated

Mar 17, 2017

Attenuated vaccines contain live viruses albeit "weakened". These viruses live such that they can induce an immune response but not strong enough to cause disease to the host. Inactivated vaccines contain inactive or "killed" viruses. The viruses were inactivated using either chemical or physical processes but retain their composition thus still allowing them to induce an immune response.

Read More

Know Why Industries are Going with the New Tide

Mar 08, 2017

Cell culture using mammalian cells has been used in bioprocessing and biopharmaceutical to produce a variety of life saving products. Mammalian cells are preferred by scientists and industries due to its relatively closer resemblance to human cells as compared to microbial, plants or insect cells. The challenge of using mammalian cells however has always been in the culture and proliferation of the cells.

Read More

BioProcess International West 2017

Feb 28, 2017

Esco VacciXcell joined the only phase-based event to break down silos for accelerating biologics from early stage process development to commercial manufacturing in the western United States!

Read More

KNOWING AVIAN INFLUENZA AND HOW TO PREVENT A PANDEMIC

Feb 15, 2017

Avian influenza, also known as avian flu or bird flu, is a type A influenza caused by viral infection in birds. Generally speaking, avian flu can only infect birds and poultry but there has been cases wherein humans were infected through direct or indirect contact with infected birds. Notable subtypes of avian flu are H5N1 and H7N9

Read More

Innovations and Advances for Bioprocessing Seminar, Hong Kong

Feb 01, 2017

Esco VacciXcell successfully conducted a seminar last January 20, 2017 in HKPC Building, 78 Tat Chee Aveneu, Kowloon Tong, Hong Kong. Lead by Mr. Liang Ke, product specialist, and Ms. MK Kim, application specialist, the seminar entitled "Innovations and Advances for Bioprocessing" welcomed attendees to a day of learning on the new technologies and processes on bioprocessing, specifically in the field of cell therapy.

Read More

FEATURED CLIENT: MEDIGEN VACCINE BIOLOGICS CO

Jan 27, 2017

In 2009, the H1N1 pandemic was bringing panic to the whole world due to its infection rate and lethality. In response to this threat, Medigen Biotechnology Corporation (MBC) decided to create a vaccine division which would integrate innovative technology that would be able to produce necessary vaccines in large volumes within a short period of time.

Read More

ARE YOUR CELLS GETTING ENOUGH GLUCOSE?

Jan 17, 2017

During in-vitro cell culture, it is important that the culture environment mimic the chosen cell line's original in-vivo environment for it to grow and propagate. Glucose, being the main source of energy for heterotrophic cells, is one of the parameters that should be carefully monitored during the culturing process.

Read More

CPhI and P-MEC India 2016

Nov 25, 2016

Esco VacciXcell alongside Esco Biotech (India) Pvt. Ltd. Participated in the recently concluded CPhI-India and P-MEC held last November 21 - 23, 2016 at MMRDA Grounds, BKC in Mumbai, India.

Read More

VACCIXCELL BIOPROCESSING SEMINARS: A RISING TIDE LIFTS ALL BOATS

Nov 14, 2016

Esco VacciXcell has conducted two seminars within the past few months that is aimed to educate and enlighten people from the scientific community of the revolutionary technology that is the TideMotion bioreactor system.

Read More

Catching the Tide: How VacciXcell's TideMotion Bioreactor is Innovating Bioprocessing

Nov 08, 2016

Biopharmaceutical companies and industries around the world use cell culture as a means of producing their bio products. Whether the company is producing vaccines, monoclonal anti-bodies, proteins, biosimilars or stem cells, using some type of bioreactor is the widely accepted and most efficient method of doing it.

Read More

VacciXcell at the AAVLD/USAHA Annual Meeting 2016

Oct 25, 2016

The American Association of Veterinary Laboratory Diagnosticians (AAVLD) and the United States Animal Health Association (USAHA) held their 59th and 120th annual meetings, respectively, at Sheraton Greensboro, North Carolina last October 13-19, 2016. The meeting was well attended by both members and non-members of both associations.

Read More

VacciXcell™ Hybrid Bioreactor

Oct 21, 2016

Biopharmaceuticals are therapeutics derived from biological sources; they are a promising and growing trend in the treatment of diseases. In contrast to their synthetic counterparts, biopharmaceuticals are much more specific and targeted and therefore have fewer side effects. Furthermore, they do not merely treat the symptoms of diseases but can treat the diseases at their cause.

Read More

Go with the Tide: ISCT North America Regional Meeting 2016 & Boston Biotech Week Exhibits

Oct 14, 2016

The International Society of Cell Therapy held its annual North America Regional Meeting at the Peabody in Memphis, Tennessee last September 30 to October 2. The event was well attended by experts in the field of Cell Therapy such as medical doctors, clinicians, scientists, regulatory experts, and laboratory professionals and industry personnel involved in cell processing facilities and programs in North America.

Read More

INVITATION TO WORLD VACCINE CONGRESS EUROPE AND AAVLD ANNUAL MEETING 2016

Sep 29, 2016

Europe's most successful vaccine event is now entering its 17th year. For 16 years the World Vaccine Congress in Europe has been the leading event to talk about scientific advances and find new business opportunities within the vaccine sector and this year is no exception.

Read More

REACHING EAST AND WEST:

Sep 07, 2016

The 2016 International Society of Pharmaceutical (ISPE) conference held at the Suntec Convention and Exhibition Center in Singapore has concluded last August 26 with more than 100 local and international companies participating in the event.

Read More

VacciXcell conducts product training for International Atomic Energy Agency

Aug 12, 2016

Dr. Mudasser Habib, is a principal scientist whose research focuses on the development of vaccine for PPR virus for goat cells has participated in a product training for CelCradle™, TideCell™ and StirCradle™, bioreactors conducted by the VacciXcell Esco Healthcare last August 1-12, 2016 at the Esco Ventures, Singapore.

Read More

VacciXcell™ Hybrid Bioreactor

Aug 10, 2016

Biopharmaceuticals are therapeutics derived from biological sources; they are a promising and growing trend in the treatment of diseases. In contrast to their synthetic counterparts, biopharmaceuticals are much more specific and targeted and therefore have fewer side effects.

Read More

The International Society of Cellular Therapy (ISCT) 2016

Jun 01, 2016

VacciXcell was recently at The International Society of Cellular Therapy (ISCT) in Singapore. Held at the Suntec Convention and Exhibition Centre, the 22nd Annual Scientific Meeting was held in Asia for the first time.

Read More

Vaccine BioProcessing Seminar

May 25, 2016

One of VacciXcell’s main visions is a world of vaccine self-sufficiency for all nations, including developing ones and conducting free end-user seminars is one of VacciXcell’s ways to fulfil this vision. These end-user seminars help increase awareness of current news and situations in the vaccine industry and as well as the latest trends and techniques in vaccine bioprocessing;

Read More

Introducing the Esco TideCell®

May 06, 2016

VacciXcell’s TideCell® System takes vaccine production to a higher level, with new enhanced features and more options for better flexibility. Users can choose between single-use and multiple-use and different capacities and options for the different components of the TideCell® system.

Read More

Zoonotic Outbreaks: The VacciXcell Solution

May 02, 2016

When an animal epidemic breaks out, the economy suffers grave losses due to agricultural losses, as the infected animals can die or their meat, milk, and other products are no longer fit for human consumption. Moreover, sanitation and immunization in farms are not well established and thus, diseases can easily spread among the herd, leading to further losses.

Read More

World Vaccine Congress USA 2016

Apr 04, 2016

VacciXcell was present at the recently concluded World Vaccine Congress USA 2016 held at the Grand Hyatt Washington DC. The Congress, which ran for 3 days, consisted of 7 conferences namely World Vaccine Cancer & Immunotherapy, World Vaccine Influenza & Respiratory, World Vaccine Emerging & Re-Imerging, World Vaccine Clinical Trials, World Vaccine Bioprocessing & Manufacturing, World Vaccine Veterinary, and World Vaccine Partnerships.

Read More

Esco VacciXcell commences the first day of World Vaccine Congress USA 2016 in Washington DC

Mar 29, 2016

For the first time, our production scale packed bed 2 liter bioreactor, with pH and DO control, was displayed and launched in the American market, drawing huge attention and positive feedback from various delegates.

Read More

Arab Lab 2016

Mar 24, 2016

VacciXcell, together with Esco, visited Dubai again for the second time this year to attend Arab Lab 2016, which was held last 20-23 March 2016 at the Dubai World Trade Center. VacciXcell reintroduced the CelCradle to the Middle East, this time brining the unit to the exhibition.

Read More

Zika Virus and Pandemic Outbreaks: The VacciXcell Solution

Mar 18, 2016

In September 2012, the first case of the deadly Mers-Cov virus was reported in the Middle East and has since then spread within the Arabian Peninsula. In 2015, the largest Mers-Cov outbreak outside the Arabian Peninsula occurred in South Korea. According to WHO, there is a total of 591 Mers-Cov related deaths since 2012 among the 1652 reported cases in 26 countries around the world.

Read More

VacciXcell coming to you in Middle East!

Jan 29, 2016

VacciXcell is currently in Dubai with the Esco Group of Companies exhibiting our innovative CelCradle Biorea

Read More

Innovative cold chain solution from VacciXcell

Dec 16, 2015

VacciXcell is proud to be awarded a walk in chiller project for a developing country for vaccine storage.

Read More

VacciXcell commences the 1st day of exhibition at the Europe Vaccine Congress 2015 in Madrid

Nov 10, 2015

VacciXcell, a subsidiary of Esco Group of companies, completes day 1 of the European Vaccine Congress. Of great interest is our latest CelCradle Single-Use Bioreactor that drew large responses from the international delegates.

Read More

Esco Launches VacciXcell and TapestleRx

Nov 10, 2015

Esco group of companies is excited to launch 2 new platforms VacciXcell and TaPestle Rx!

Read More

9th Vaccine & ISV Congress

Oct 28, 2015

VacciXcell exhibited at the 9th Vaccine & ISV Congress held on 18-20th October at Lotte Hotel in Seoul, Korea. Products featured at the booth were the BelloCell® bioreactor system and the CelSafe® CO2 Incubator, which is an excellent combination for vaccine development.

Read More

Official Launch of VacciXcell at World Vaccine Congress Asia

Jun 10, 2015

VacciXcell officially launched in Singapore on 3-4 June, 2015 at Suntec Convention and Exhibition Centre during World Vaccine Congress Asia! We are excited to embark on this journey with you, offering turnkey solutions to clients of all applications and budgets.

Read More